Company intelligence / Profile preview

Pyramid Studio

Ownership: Private
Development stage: Preclinical

Overview

Pyramid Studio scouts and de-risks breakthrough academic innovations in immunology/inflammation, neurological disorders, and rare diseases. It advances these assets to near-clinic readiness for pharmaceutical partners but does not itself conduct clinical trials or commercialize drugs directly

Therapeutic areas: Rare DiseasesImmunologyNeurology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Works with large pharmaceutical companies and biotech firms as clients/partners; specific names not disclosed

Beyond the preview

Go deeper on Pyramid Studio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyramid Studio.

Explore the full profile